We were thrilled to see that Dakim
has raised $10.6 million in Series C financing, in a transaction led by Galen Partners.
Dakim is an innovated provider of brain fitness technology
to improve the quality of life for Alzheimer's patients.
Growthink assisted Dakim in the drafting of their business
plan, and in assessing the market for non-drug Alzheimer's-related products and
services -- so we're especially proud of the company's success. We're happy
that we've been able to play a role in their growth.